Peter Wilmshurst is a British medical doctor and successful whistleblower who has been the subject of multiple cases of harassment through vexatious libel actions[1] brought by companies whose products he criticised as ineffective.
[1][2] In 1986, Wilmshurst, a cardiologist then working at St. Thomas' Hospital, London, approached The Guardian newspaper with a substantial dossier detailing alleged misconduct in the development of amrinone, a cardiac drug manufactured by Sterling-Winthrop.
He continued the research and published his adverse findings in abstracts and conference presentations, until Sterling-Winthrop staff removed all stocks of the drug from the hospital pharmacy.
[1] Less than a fortnight after returning from a conference in Washington, where he discussed his results, Wilmshurst was contacted by lawyers for NMT making accusations of "seriously defamatory allegations".
[7] In light of the Hadiza Bawa-Garba case, Dr Peter Wilmshurst has referred himself to the GMC and asked the regulatory body to both remove himself from the register and scrutinise his medical practice.
[8] Wilmshurst's experience, along with British Chiropractic Association v Singh, have been cited as catalysts for the UK's libel reform campaign, leading to the Defamation Act 2013.